397 related articles for article (PubMed ID: 12569961)
1. Review of the FDA-approved uses of botulinum toxins, including data suggesting efficacy in pain reduction.
Lew MF
Clin J Pain; 2002; 18(6 Suppl):S142-6. PubMed ID: 12569961
[TBL] [Abstract][Full Text] [Related]
2. A new botulinum toxin (Xeomin) for cervical dystonia and blepharospasm.
Med Lett Drugs Ther; 2010 Nov; 52(1351):90-1. PubMed ID: 21068703
[TBL] [Abstract][Full Text] [Related]
3. Safety, effectiveness, and duration of effect of BOTOX after switching from Dysport for blepharospasm, cervical dystonia, and hemifacial spasm dystonia, and hemifacial spasm.
Bihari K
Curr Med Res Opin; 2005 Mar; 21(3):433-8. PubMed ID: 15811212
[TBL] [Abstract][Full Text] [Related]
4. [Botulinum toxin therapy for focal dystonia].
Hahn K; Niklai E; Garzuly F; Szupera Z
Orv Hetil; 2009 Jul; 150(29):1381-4. PubMed ID: 19581172
[TBL] [Abstract][Full Text] [Related]
5. Comparison of botulinum neurotoxin preparations for the treatment of cervical dystonia.
Chapman MA; Barron R; Tanis DC; Gill CE; Charles PD
Clin Ther; 2007 Jul; 29(7):1325-37. PubMed ID: 17825685
[TBL] [Abstract][Full Text] [Related]
6. Botulinum toxin in movement disorders.
Papapetropoulos S; Singer C
Semin Neurol; 2007 Apr; 27(2):183-94. PubMed ID: 17390263
[TBL] [Abstract][Full Text] [Related]
7. Botulinum neurotoxin serotype A: a clinical update on non-cosmetic uses.
Charles PD
Am J Health Syst Pharm; 2004 Nov; 61(22 Suppl 6):S11-23. PubMed ID: 15598005
[TBL] [Abstract][Full Text] [Related]
8. [Botulinum toxin in neurology].
Vidailhet M
Rev Med Interne; 2005 Jul; 26(7):531-3. PubMed ID: 15975692
[No Abstract] [Full Text] [Related]
9. [Clinical symptoms, diagnosis and treatment of focal dystonias].
Klivényi P; Vécsei L
Orv Hetil; 2001 Oct; 142(42):2293-7. PubMed ID: 11760645
[TBL] [Abstract][Full Text] [Related]
10. [Focal dystonias and facial hemispasm: treatment with botulinum A toxin].
Astarloa R; Morales B; Sánchez V; Peñafiel N; Rábano J; Oliván J; García de Yébenes J
Arch Neurobiol (Madr); 1991; 54 Suppl 3():44-51. PubMed ID: 1810208
[TBL] [Abstract][Full Text] [Related]
11. [Focal dystonias and facial hemispasm: treatment with botulinum A toxin].
Astarloa R; Morales B; Sánchez V; Peñafiel N; Rábano J; Oliván J; García de Yébenes J
Arch Neurobiol (Madr); 1991; 54(5):210-7. PubMed ID: 1804035
[TBL] [Abstract][Full Text] [Related]
12. Use of botulinum toxin in neuro-ophthalmology.
O'Day J
Curr Opin Ophthalmol; 2001 Dec; 12(6):419-22. PubMed ID: 11734681
[TBL] [Abstract][Full Text] [Related]
13. Botulinum A toxin injection in patients with blepharospasm, torticollis and hemifacial spasm.
Berardelli A; Carta A; Stocchi F; Formica A; Agnoli A; Manfredi M
Ital J Neurol Sci; 1990 Dec; 11(6):589-93. PubMed ID: 2081684
[TBL] [Abstract][Full Text] [Related]
14. [Mechanism of action, clinical indication and results of treatment of botulinum toxin].
Lagueny A; Burbaud P
Neurophysiol Clin; 1996; 26(4):216-26. PubMed ID: 8975111
[TBL] [Abstract][Full Text] [Related]
15. Botulinum toxin in blepharospasm and oromandibular dystonia: comparing different botulinum toxin preparations.
Bhidayasiri R; Cardoso F; Truong DD
Eur J Neurol; 2006 Feb; 13 Suppl 1():21-9. PubMed ID: 16417594
[TBL] [Abstract][Full Text] [Related]
16. Long-term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasm.
Ababneh OH; Cetinkaya A; Kulwin DR
Clin Exp Ophthalmol; 2014 Apr; 42(3):254-61. PubMed ID: 23844601
[TBL] [Abstract][Full Text] [Related]
17. Unlabeled uses of botulinum toxins: a review, part 1.
Cheng CM; Chen JS; Patel RP
Am J Health Syst Pharm; 2006 Jan; 63(2):145-52. PubMed ID: 16390928
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin for the treatment of movement disorders.
Thenganatt MA; Fahn S
Curr Neurol Neurosci Rep; 2012 Aug; 12(4):399-409. PubMed ID: 22661378
[TBL] [Abstract][Full Text] [Related]
19. Use of botulinum toxin A in the treatment of hemifacial spasm and blepharospasm.
Chang LB; Tsai CP; Liao KK; Kao KP; Yuan CL; Yen DJ; Lin KP
Zhonghua Yi Xue Za Zhi (Taipei); 1999 Jan; 62(1):1-5. PubMed ID: 10063705
[TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin B: a review of its therapeutic potential in the management of cervical dystonia.
Figgitt DP; Noble S
Drugs; 2002; 62(4):705-22. PubMed ID: 11893235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
